UNSPSC 85753404: Revision of autologous tissue substitute in epididymis and spermatic cord, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in epididymis and spermatic cord, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VWM47Z

UNSPSC 85753404, Revision of autologous tissue substitute in epididymis and spermatic cord, percutaneous endoscopic approach, is a Commodity code that does not reflect the scope of work actually being solicited by state and local governments under this designation. Recent opportunities tagged to this code involve occupational medical surveillance, independent medical evaluations for public safety pension determinations, pharmacy benefit management administration, temporary health professional staffing, surgical procedure carve-out networks, and emergency healthcare services for detained youth — none of which align with the code's nominal scope of urological tissue revision procedures. The disconnect between the code name and actual buying patterns suggests either systematic misclassification or that the code is not actively used by state and local procurement offices for work matching its clinical specification.

The issuing bodies sourced across these tagged opportunities span state departments (Washington State Department of Transportation), county health systems and commissions (Collier County, Harris County, Santa Clara County), city retirement offices and governments (Phoenix, Long Beach), and public safety pension boards. Geographic activity appears across Washington, Arizona, California, Florida, and Texas; however, the mismatch between the UNSPSC designation and the purchased services makes it difficult to characterize demand meaningfully for firms pursuing this code. No recent opportunities in the source material involve autologous tissue substitutes, urological procedures, or endoscopic revision services. Vendors should verify that work they pursue is tagged to this code in the actual RFP rather than relying on the code number alone.